Matsumura M, Saito S
Tokushima City Hospital, Japan.
Endocrinol Jpn. 1989 Feb;36(1):15-21. doi: 10.1507/endocrj1954.36.15.
The effects of bile salts on the release of immunoreactive vasoactive intestinal polypeptide (IR-VIP) were investigated in men using a specific radioimmunoassay. Plasma IR-VIP was determined after extraction by the acid-acetone method (recovery 75 +/- 5%). Oral administration of 400 mg sodium taurocholate caused a rise in plasma IR-VIP from 18.5 +/- 1.3 pmol/l to 31.1 +/- 2.1 pmol/l after 30 min and 39.0 +/- 1.7 pmol/l after 60 min and return to the initial value after 120 min. Oral administration of chenodeoxycholic acid (CDCA) also increased plasma IR-VIP from a basal level of 14.5 +/- 1.5 pmol/l to 36.3 +/- 1.2 pmol/l after 60 min. Oral administration of ursodeoxycholic acid (UDCA) increased plasma IR-VIP from 11.9 +/- 1.1 pmol/l to 25.6 +/- 1.8 pmol/l after 30 min. Perifusion of 1 mM taurocholate stimulated release of IR-VIP from human duodenal mucosa into the perifusate. These results suggest that bile salts may participate, at least in part, in the release of IR-VIP from the gut.
采用特异性放射免疫分析法,研究了胆盐对男性体内免疫反应性血管活性肠肽(IR-VIP)释放的影响。采用酸-丙酮法提取后测定血浆IR-VIP(回收率75±5%)。口服400mg牛磺胆酸钠后,30分钟时血浆IR-VIP从18.5±1.3pmol/L升至31.1±2.1pmol/L,60分钟时升至39.0±1.7pmol/L,120分钟后恢复至初始值。口服鹅去氧胆酸(CDCA)60分钟后,血浆IR-VIP也从基础水平14.5±1.5pmol/L升至36.3±1.2pmol/L。口服熊去氧胆酸(UDCA)30分钟后,血浆IR-VIP从11.9±1.1pmol/L升至25.6±1.8pmol/L。用1mM牛磺胆酸钠进行灌流刺激了IR-VIP从人十二指肠黏膜释放到灌流液中。这些结果表明,胆盐可能至少部分参与了肠道中IR-VIP的释放。